SEMA MISIR1,*, SERAP OZER YAMAN2, NINA PETROVIĆ3,4, CEREN SUMER5, CEYLAN HEPOKUR1, YUKSEL ALIYAZICIOGLU2
Oncology Research, Vol.30, No.4, pp. 157-172, 2022, DOI:10.32604/or.2022.027547
Abstract Breast cancer (BC) is the most common heterogeneous disease in women and one of the leading causes of
cancer-related death. Surgery, chemotherapy, radiotherapy, hormone, and targeted therapy are the gold standards for
BC treatment. One of the significant challenges during the treatment of BC represents resistance to
chemotherapeutics, resistance that severely limits the use and effectiveness of the drugs used for BC treatment.
Therefore, it is essential to develop new strategies to improve therapeutic efficacy. Circular RNAs (circRNAs) are a
large group of non-coding RNAs that covalently form closed circular loops by joining their 5′, and 3′; ends.
Accumulating evidence… More >
Login
Register
